Advertisement

Sun Pharma, Lupin recall products in US market

Sun Pharma is recalling 696 bottles of Pregabalin capsules (50 mg), while Lupin, on the other hand, is recalling 50,832 bottles of Gatifloxacin Ophthalmic Solution, according to US FDA report.

Agencies | Updated on: Sunday, January 16, 2022, 04:52 PM IST

As per the US FDA, Lupin's US-based unit is recalling the affected lot due to 'failed stability specifications. |
As per the US FDA, Lupin's US-based unit is recalling the affected lot due to 'failed stability specifications. |
Advertisement

Sun Pharmaceutical Industries and Lupin Ltd are recalling products in the US, for different reasons.

Sun Pharma is recalling 696 bottles of Pregabalin capsules (50 mg), used for the treatment of epilepsy, anxiety, and nerve pain, in the US market, while Lupin, is recalling 50,832 bottles of Gatifloxacin Ophthalmic Solution, an antibiotic used to treat bacterial infections of the eyes, according to US Food and Drug Administration (US FDA) report.

As per the US FDA, the company's US-based unit is recalling the affected lot due to ''failed stability specifications: out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.''

The United States Food and Drug Administration (US FDA) is a federal agency of the Department of Health and Human Services. The FDA is responsible for protecting and promoting public health.

(With inputs from PTI)

(To receive our E-paper on whatsapp daily, please click here. To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

Published on: Sunday, January 16, 2022, 04:53 PM IST